summit study tirzepatide hfpef trial In pts wiht HFpEF and obesity, tirzepatide (Mounjaro®) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in trial https://t.co/8ZHm4gySiL Effects of tirzepatide on circulatory
Pay in 4 interest-free payments of $6.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
























